Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.

Määttä M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A.

Acta Obstet Gynecol Scand. 2010 Mar;89(3):380-4. doi: 10.3109/00016340903555990.

PMID:
20109015
[PubMed - indexed for MEDLINE]
2.

[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].

Zhou CY, Yao JF, Chen XD.

Ai Zheng. 2002 Jul;21(7):735-9. Chinese.

PMID:
12479097
[PubMed - indexed for MEDLINE]
3.

Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.

Maeta H, Ohgi S, Terada T.

Virchows Arch. 2001 Feb;438(2):121-8.

PMID:
11253113
[PubMed - indexed for MEDLINE]
4.

Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.

Sakata K, Shigemasa K, Nagai N, Ohama K.

Int J Oncol. 2000 Oct;17(4):673-81.

PMID:
10995877
[PubMed - indexed for MEDLINE]
5.

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.

Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2004 Jan 15;10(2):634-40.

PMID:
14760086
[PubMed - indexed for MEDLINE]
Free Article
6.

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.

Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.

Cancer. 2005 Apr 15;103(8):1676-84.

PMID:
15754326
[PubMed - indexed for MEDLINE]
Free Article
7.

[Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].

Wei QY, Wu YQ, Fan SQ.

Hunan Yi Ke Da Xue Xue Bao. 2003 Jun;28(3):212-6. Chinese.

PMID:
14653069
[PubMed - indexed for MEDLINE]
8.

Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.

Sogawa K, Kondo K, Fujino H, Takahashi Y, Miyoshi T, Sakiyama S, Mukai K, Monden Y.

Cancer. 2003 Nov 1;98(9):1822-9.

PMID:
14584061
[PubMed - indexed for MEDLINE]
Free Article
9.

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R.

Gynecol Oncol. 1999 Jun;73(3):372-82.

PMID:
10366463
[PubMed - indexed for MEDLINE]
10.

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.

Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.

Int J Mol Med. 2005 Oct;16(4):541-6.

PMID:
16142384
[PubMed - indexed for MEDLINE]
11.

Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Anticancer Res. 2006 Mar-Apr;26(2B):1543-56.

PMID:
16619570
[PubMed - indexed for MEDLINE]
Free Article
12.

Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.

Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.

Am J Clin Oncol. 2008 Feb;31(1):55-63. doi: 10.1097/COC.0b013e318068b4e2.

PMID:
18376229
[PubMed - indexed for MEDLINE]
13.

Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.

Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Daraï E.

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1911-7.

PMID:
17009991
[PubMed - indexed for MEDLINE]
14.

A comparative study of MMP-2 in vulvar neoplasms.

Bovo AC, da Silva ID, Takita LC, Fochi J, Stávale JN, Marks G, de Lima GR.

Gynecol Oncol. 2004 May;93(2):454-7.

PMID:
15099961
[PubMed - indexed for MEDLINE]
15.

Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.

Hoikkala S, Pääkkö P, Soini Y, Mäkitaro R, Kinnula V, Turpeenniemi-Hujanen T.

Cancer Lett. 2006 May 8;236(1):125-32. Epub 2005 Jun 27. Erratum in: Cancer Lett. 2007 Mar 18;247(2):359.

PMID:
15982804
[PubMed - indexed for MEDLINE]
16.

[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].

Zheng Y, Ding J, Wang CL, Jiao SS, Qu LM, Bahargul, Bao H, Chen X.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Apr;46(4):299-302. Chinese.

PMID:
21624249
[PubMed - indexed for MEDLINE]
17.

Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.

Hara I, Miyake H, Hara S, Arakawa S, Kamidono S.

J Urol. 2001 May;165(5):1769-72.

PMID:
11342973
[PubMed - indexed for MEDLINE]
18.
19.

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.

Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.

Anticancer Res. 2000 Mar-Apr;20(2B):1311-6.

PMID:
10810441
[PubMed - indexed for MEDLINE]
20.

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.

Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, Suzuki H.

Invasion Metastasis. 1998-1999;18(3):134-41.

PMID:
10474026
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk